カテゴリー： GlobalInfoResearch, 世界

ハンター症候群治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Hunter Syndrome Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9100020）・商品コード：GIR9100020
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年10月9日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、ハンター症候群治療の世界市場について調べ、まとめました。種類別セグメントは、酵素補充療法（ERT）、造血幹細胞移植（HSCT）、その他等、用途別セグメントは、ライフサイエンス企業、研究所、病院等に区分しました。ハンター症候群治療の世界市場概観、企業動向、企業別ハンター症候群治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・ハンター症候群治療の市場概観
・ハンター症候群治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・ハンター症候群治療の企業別販売動向、市場シェア、市場集中度、競争動向
・ハンター症候群治療の世界市場規模
・ハンター症候群治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・ハンター症候群治療のアメリカ市場規模推移
・ハンター症候群治療のカナダ市場規模推移
・ハンター症候群治療のメキシコ市場規模推移
・ハンター症候群治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・ハンター症候群治療のドイツ市場規模推移
・ハンター症候群治療のイギリス市場規模推移
・ハンター症候群治療のロシア市場規模推移
・ハンター症候群治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・ハンター症候群治療の日本市場規模推移
・ハンター症候群治療の中国市場規模推移
・ハンター症候群治療の韓国市場規模推移
・ハンター症候群治療のインド市場規模推移
・ハンター症候群治療の東南アジア市場規模推移
・ハンター症候群治療の南米市場分析（ブラジル、アルゼンチン等）
・ハンター症候群治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・ハンター症候群治療の種類別分析/販売量、売上、市場シェア（酵素補充療法（ERT）、造血幹細胞移植（HSCT）、その他）
・ハンター症候群治療の用途別分析/市場規模（ライフサイエンス企業、研究所、病院）
・ハンター症候群治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・ハンター症候群治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The global Hunter Syndrome Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hunter Syndrome Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Hunter Syndrome Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hunter Syndrome Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Inventiva S.A.
Denali Therapeutics Inc.
RegenxBio Inc.
GC Pharma.
Shire Plc.
JCR Pharmaceuticals Co Ltd.
Esteve. 
ArmaGen Inc.
Sangamo Therapeutics, Inc.
Bioasis Technologies Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Enzyme Replacement Therapy (ERT)
Hematopoietic Stem Cell Transplant (HSCT)
Others

Market Segment by Applications, can be divided into
Life Science Companies
Research Institutes
Hospital

【レポートの目次】

Table of Contents

1 Hunter Syndrome Treatment Market Overview
1.1 Product Overview and Scope of Hunter Syndrome Treatment
1.2 Classification of Hunter Syndrome Treatment by Types
1.2.1 Global Hunter Syndrome Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Hunter Syndrome Treatment Revenue Market Share by Types in 2018
1.2.3 Enzyme Replacement Therapy (ERT)
1.2.4 Hematopoietic Stem Cell Transplant (HSCT)
1.2.5 Others
1.3 Global Hunter Syndrome Treatment Market by Application
1.3.1 Global Hunter Syndrome Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Life Science Companies
1.3.3 Research Institutes
1.3.4 Hospital
1.4 Global Hunter Syndrome Treatment Market by Regions
1.4.1 Global Hunter Syndrome Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hunter Syndrome Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Hunter Syndrome Treatment (2014-2024)
2 Company Profiles
2.1 Inventiva S.A.
2.1.1 Business Overview
2.1.2 Hunter Syndrome Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Inventiva S.A. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Denali Therapeutics Inc.
2.2.1 Business Overview
2.2.2 Hunter Syndrome Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Denali Therapeutics Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 RegenxBio Inc.
2.3.1 Business Overview
2.3.2 Hunter Syndrome Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 RegenxBio Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 GC Pharma.
2.4.1 Business Overview
2.4.2 Hunter Syndrome Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GC Pharma. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Shire Plc.
2.5.1 Business Overview
2.5.2 Hunter Syndrome Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Shire Plc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 JCR Pharmaceuticals Co Ltd.
2.6.1 Business Overview
2.6.2 Hunter Syndrome Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Esteve. 
2.7.1 Business Overview
2.7.2 Hunter Syndrome Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Esteve.  Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 ArmaGen Inc.
2.8.1 Business Overview
2.8.2 Hunter Syndrome Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 ArmaGen Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sangamo Therapeutics, Inc.
2.9.1 Business Overview
2.9.2 Hunter Syndrome Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Bioasis Technologies Inc.
2.10.1 Business Overview
2.10.2 Hunter Syndrome Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bioasis Technologies Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hunter Syndrome Treatment Market Competition, by Players
3.1 Global Hunter Syndrome Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Hunter Syndrome Treatment Players Market Share
3.2.2 Top 10 Hunter Syndrome Treatment Players Market Share
3.3 Market Competition Trend
4 Global Hunter Syndrome Treatment Market Size by Regions
4.1 Global Hunter Syndrome Treatment Revenue and Market Share by Regions
4.2 North America Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
5 North America Hunter Syndrome Treatment Revenue by Countries
5.1 North America Hunter Syndrome Treatment Revenue by Countries (2014-2019)
5.2 USA Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6 Europe Hunter Syndrome Treatment Revenue by Countries
6.1 Europe Hunter Syndrome Treatment Revenue by Countries (2014-2019)
6.2 Germany Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6.4 France Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Hunter Syndrome Treatment Revenue by Countries
7.1 Asia-Pacific Hunter Syndrome Treatment Revenue by Countries (2014-2019)
7.2 China Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7.5 India Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
8 South America Hunter Syndrome Treatment Revenue by Countries
8.1 South America Hunter Syndrome Treatment Revenue by Countries (2014-2019)
8.2 Brazil Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Hunter Syndrome Treatment by Countries
9.1 Middle East and Africa Hunter Syndrome Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
10 Global Hunter Syndrome Treatment Market Segment by Type
10.1 Global Hunter Syndrome Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Hunter Syndrome Treatment Market Forecast by Type (2019-2024)
10.3 Enzyme Replacement Therapy (ERT) Revenue Growth Rate (2014-2024)
10.4 Hematopoietic Stem Cell Transplant (HSCT) Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Hunter Syndrome Treatment Market Segment by Application
11.1 Global Hunter Syndrome Treatment Revenue Market Share by Application (2014-2019)
11.2 Hunter Syndrome Treatment Market Forecast by Application (2019-2024)
11.3 Life Science Companies Revenue Growth (2014-2019)
11.4 Research Institutes Revenue Growth (2014-2019)
11.5 Hospital Revenue Growth (2014-2019)
12 Global Hunter Syndrome Treatment Market Size Forecast (2019-2024)
12.1 Global Hunter Syndrome Treatment Market Size Forecast (2019-2024)
12.2 Global Hunter Syndrome Treatment Market Forecast by Regions (2019-2024)
12.3 North America Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
12.6 South America Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Hunter Syndrome Treatment Picture
Table Product Specifications of Hunter Syndrome Treatment
Table Global Hunter Syndrome Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Hunter Syndrome Treatment Revenue Market Share by Types in 2018
Figure Enzyme Replacement Therapy (ERT) Picture
Figure Hematopoietic Stem Cell Transplant (HSCT) Picture
Figure Others Picture
Table Global Hunter Syndrome Treatment Revenue (Million USD) by Application (2014-2024)
Figure Hunter Syndrome Treatment Revenue Market Share by Applications in 2018
Figure Life Science Companies Picture
Figure Research Institutes Picture
Figure Hospital Picture
Table Global Market Hunter Syndrome Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Inventiva S.A. Basic Information, Manufacturing Base and Competitors
Table Inventiva S.A. Hunter Syndrome Treatment Type and Applications
Table Inventiva S.A. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Denali Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table Denali Therapeutics Inc. Hunter Syndrome Treatment Type and Applications
Table Denali Therapeutics Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table RegenxBio Inc. Basic Information, Manufacturing Base and Competitors
Table RegenxBio Inc. Hunter Syndrome Treatment Type and Applications
Table RegenxBio Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GC Pharma. Basic Information, Manufacturing Base and Competitors
Table GC Pharma. Hunter Syndrome Treatment Type and Applications
Table GC Pharma. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Plc. Basic Information, Manufacturing Base and Competitors
Table Shire Plc. Hunter Syndrome Treatment Type and Applications
Table Shire Plc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table JCR Pharmaceuticals Co Ltd. Basic Information, Manufacturing Base and Competitors
Table JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Type and Applications
Table JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Esteve.  Basic Information, Manufacturing Base and Competitors
Table Esteve.  Hunter Syndrome Treatment Type and Applications
Table Esteve.  Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table ArmaGen Inc. Basic Information, Manufacturing Base and Competitors
Table ArmaGen Inc. Hunter Syndrome Treatment Type and Applications
Table ArmaGen Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Type and Applications
Table Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bioasis Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table Bioasis Technologies Inc. Hunter Syndrome Treatment Type and Applications
Table Bioasis Technologies Inc. Hunter Syndrome Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Hunter Syndrome Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Hunter Syndrome Treatment Revenue Share by Players (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Players in 2017
Figure Global Hunter Syndrome Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Hunter Syndrome Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Hunter Syndrome Treatment Revenue Market Share in 2018
Figure Global Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Hunter Syndrome Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Hunter Syndrome Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Market Share by Regions in 2018
Figure North America Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure South America Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table North America Hunter Syndrome Treatment Revenue by Countries (2014-2019)
Table North America Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure USA Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table Europe Hunter Syndrome Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure Germany Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure UK Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure France Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Hunter Syndrome Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure China Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure India Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table South America Hunter Syndrome Treatment Revenue by Countries (2014-2019)
Table South America Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure Brazil Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Hunter Syndrome Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Hunter Syndrome Treatment Revenue and Growth Rate (2014-2019)
Table Global Hunter Syndrome Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Hunter Syndrome Treatment Revenue Share by Type (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Type (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Type in 2018
Table Global Hunter Syndrome Treatment Revenue Forecast by Type (2019-2024)
Figure Global Hunter Syndrome Treatment Market Share Forecast by Type (2019-2024)
Figure Global Enzyme Replacement Therapy (ERT) Revenue Growth Rate (2014-2019)
Figure Global Hematopoietic Stem Cell Transplant (HSCT) Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Hunter Syndrome Treatment Revenue by Application (2014-2019)
Table Global Hunter Syndrome Treatment Revenue Share by Application (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Application (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue Share by Application in 2018
Table Global Hunter Syndrome Treatment Revenue Forecast by Application (2019-2024)
Figure Global Hunter Syndrome Treatment Market Share Forecast by Application (2019-2024)
Figure Global Life Science Companies Revenue Growth Rate (2014-2019)
Figure Global Research Institutes Revenue Growth Rate (2014-2019)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Hunter Syndrome Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Hunter Syndrome Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Hunter Syndrome Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
Figure Europe Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
Figure South America Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Hunter Syndrome Treatment Revenue Market Forecast (2019-2024)


【掲載企業】

Inventiva S.A.、 Denali Therapeutics Inc.、 RegenxBio Inc.、 GC Pharma.、 Shire Plc.、 JCR Pharmaceuticals Co Ltd.、 Esteve. 、 ArmaGen Inc.、 Sangamo Therapeutics, Inc.、 Bioasis Technologies Inc.

★調査レポート[ハンター症候群治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9100020)販売に関する免責事項を必ずご確認ください。
★調査レポート[ハンター症候群治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 呼吸促迫症候群の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103706 / GlobalInfoResearch / 2019年9月30日 / 本調査レポートは、呼吸促迫症候群の世界市場について調べ、まとめました。種類別セグメントは、多孔剤アルファ、ベラクタント、カルファクタント、その他等、用途別セグメントは、非常に早産児、中期から後期の早産児、その他等に区分しました。呼吸促迫症候群の世界市場概観、企業動向、企業別呼吸促迫症候群シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・呼吸促迫症候群の市場概観 ・呼吸促迫症候群の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・呼吸促迫症候群の企業別販売動向、市場シェア、市場集中度、競争動向 ・呼吸促迫症候群の世界市場規模 ・呼吸促迫症候群の北米市場分析（アメリカ、カナダ、メキシコ等） ・呼吸促迫症候群のアメリカ市場規模推移 ・呼吸促迫症候群のカナダ市場規模推移 ・呼吸促迫症候群のメキシコ市場規模推移 ・呼吸促迫症候群のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Respiratory Distress Syndrome market is valued at 360.1 million USD in 2018 and is expected to reach 442.6 million USD by the end of 2024, growing at a CAGR of 5.3% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Respiratory Distress Syndrome. Europe also play important roles in...
  • 概日リズム睡眠治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101307 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、概日リズム睡眠治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、光線療法等、用途別セグメントは、遅延睡眠相症候群（DSPS）、高度睡眠相症候群（ASPS）、不規則な睡眠覚醒障害（ISWD）、その他等に区分しました。概日リズム睡眠治療の世界市場概観、企業動向、企業別概日リズム睡眠治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・概日リズム睡眠治療の市場概観 ・概日リズム睡眠治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・概日リズム睡眠治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・概日リズム睡眠治療の世界市場規模 ・概日リズム睡眠治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・概日リズム睡眠治療のアメリカ市場規模推移 ・概日リズム睡眠治療のカナダ市場規模推移 ・概日リズム睡眠治療のメキシコ市場規模推移 ・概日リズム睡眠治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A circadian rhythm is any biological process that displays an endogenous, entrainable oscillation of about 24 hours. These 24-hour rhythms are driven by a circadian clock, and they have been widely observed in plants, animals, fungi, and cyanobacteria. Circadian rhythm sleep treatment follows two pathways, which include utilizing drug therapy or light therapy that involves the usage of certain devices. Scope of the Report: The global Circadian Rhythm Sleep Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019...
  • ジェットラグ治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103709 / GlobalInfoResearch / 2019年9月30日 / 本調査レポートは、ジェットラグ治療の世界市場について調べ、まとめました。種類別セグメントは、処方薬、OTC等、用途別セグメントは、病院薬局、小売薬局、オンライン等に区分しました。ジェットラグ治療の世界市場概観、企業動向、企業別ジェットラグ治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ジェットラグ治療の市場概観 ・ジェットラグ治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ジェットラグ治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・ジェットラグ治療の世界市場規模 ・ジェットラグ治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・ジェットラグ治療のアメリカ市場規模推移 ・ジェットラグ治療のカナダ市場規模推移 ・ジェットラグ治療のメキシコ市場規模推移 ・ジェットラグ治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Jet Lag Treatment market is valued at 384.1 million USD in 2018 and is expected to reach 449.9 million USD by the end of 2024, growing at a CAGR of 4.0% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Jet Lag Treatment. Europe also play important roles in...
  • 自動車表面処理/熱処理の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103059 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、自動車表面処理/熱処理の世界市場について調べ、まとめました。種類別セグメントは、化学処理、熱処理、その他等、用途別セグメントは、乗用車、商用車等に区分しました。自動車表面処理/熱処理の世界市場概観、企業動向、企業別自動車表面処理/熱処理シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・自動車表面処理/熱処理の市場概観 ・自動車表面処理/熱処理の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・自動車表面処理/熱処理の企業別販売動向、市場シェア、市場集中度、競争動向 ・自動車表面処理/熱処理の世界市場規模 ・自動車表面処理/熱処理の北米市場分析（アメリカ、カナダ、メキシコ等） ・自動車表面処理/熱処理のアメリカ市場規模推移 ・自動車表面処理/熱処理のカナダ市場規模推移 ・自動車表面処理/熱処理のメキシコ市場規模推移 ・自動車表面処理/熱処理のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Heat treatment and surface modification are the key technologies available today, to enhance the effective use of materials, to achieve the desired properties of the components used in the automotive industries, to save energy and conserve natural resources. Scope of the Report: Heat treatment is a type of surface treatment that includes hardening and thermal diffusion. The global Automotive Surface Treatment/Heat Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in...

    • ◆H&Iグローバルリサーチのお客様（例）◆